Top 21 Faze Medicines investors
The most complete profiles first. Showing 21 of 21.
Christoph LengauerVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Craig MuirVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Eli CasdinVerified
Venture Capital, Founder, Micro VC · United States
SeedHealth CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more
Verified email available
Robert TepperVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Noreen RizviVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Philippe LaffontVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Immunai, Freenome, Sensei Biotherapeutics, ATAI Life Sciences and 10 more
Verified email available
Tom BrooksVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Immunai, Freenome, Sensei Biotherapeutics, ATAI Life Sciences and 10 more
Verified email available
Abbie Celniker
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more
Contact details available
Cary Pfeffer
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
George Xu
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Mark Levin
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceEducationPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Matthew J. Hobson
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedInvestment ManagementPortfolio: Immunai, Freenome, Sensei Biotherapeutics, ATAI Life Sciences and 10 more
Contact details available
Nathan Livingston
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Immunai, Freenome, Sensei Biotherapeutics, ATAI Life Sciences and 10 more
Contact details available
Neil Exter
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
R. Jacob Vogelstein
Venture Capital, Founder, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Immunai, Freenome, Sensei Biotherapeutics, eNeura Therapeutics and 11 more
Contact details available
Adeline Oursler
Micro VC · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more
Contact details available
Cody Tranbarger
Micro VC · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more
Contact details available
Kelly Moynihan
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Lauren Dennison
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Immunai, Freenome, Sensei Biotherapeutics, ATAI Life Sciences and 10 more
Contact details available
Walter Kowtoniuk
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
William Motley
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Frequently asked questions
How many Faze Medicines investors are on Angel Roster?
Angel Roster lists 21 Faze Medicines investors. 7 of them (33%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (19), Private Equity Firms (6) and Micro VC Firms (3). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Faze Medicines investors invest in?
Among those that list a stage, the most common are Seed (12).
Where are Faze Medicines investors based?
Most are based in the United States (21).
Which companies have Faze Medicines investors backed?
The most-backed portfolio companies among them are Jounce Therapeutics (15), Magenta Therapeutics (15), CytomX Therapeutics (15), Relay Therapeutics (15) and Goldfinch Biopharma (15).
How do I contact Faze Medicines investors?
Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.